# Policosanol for the Treatment of Hypercholesterolemia

> **NCT00255216** · NA · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 40 (—)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** Policosanol supplement (oral capsule) vs. placebo

## Key facts

- **NCT ID:** NCT00255216
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 40 (—)
- **Last updated:** 2023-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00255216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00255216, "Policosanol for the Treatment of Hypercholesterolemia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00255216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*